John Hardy is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
John Hardy is a leading researcher in the field of neurodegenerative diseases, affiliated with University College London and NIH. Their research focuses on Amyloid, Genetics, [APP[/entities/[app-protein[/entities/[app-protein[/entities/[app-protein--TEMP--/entities)--FIX-- processing, with particular emphasis on Alzheimer's Disease and Parkinson's Disease. With an h-index of 250, Hardy is among the most cited researchers in the neuroscience field.
Hardy's work spans multiple aspects of neurodegeneration, contributing to our understanding of the molecular mechanisms that underlie diseases such as Alzheimer's Disease and Parkinson's Disease. Their research group has made significant contributions to the fields of Amyloid, Genetics, APP processing, publishing in high-impact journals including Nature, Science.
Based at University College London and NIH, Hardy collaborates with researchers across multiple institutions worldwide, working to advance therapeutic strategies for neurodegenerative conditions.
- [Alzheimer's Disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--
- [Parkinson's Disease[/diseases/[parkinsons[/diseases/[parkinsons[/diseases/[parkinsons--TEMP--/diseases)--FIX--
- [Amyloid[/mechanisms/[amyloid-hypothesis[/mechanisms/[amyloid-hypothesis[/mechanisms/[amyloid-hypothesis--TEMP--/mechanisms)--FIX--
- [Genetics[/mechanisms/[familial-alzheimers-genetics[/mechanisms/[familial-alzheimers-genetics[/mechanisms/[familial-alzheimers-genetics--TEMP--/mechanisms)--FIX--
- [APP processing[/mechanisms/[app-processing[/mechanisms/[app-processing[/mechanisms/[app-processing--TEMP--/mechanisms)--FIX--
¶ Collaborators and Research Network
[Dennis J. Selkoe[/researchers/[dennis-selkoe[/researchers/[dennis-selkoe[/researchers/[dennis-selkoe--TEMP--/researchers)--FIX--, [Michel Goedert[/researchers/[michael-goedert[/researchers/[michael-goedert[/researchers/[michael-goedert--TEMP--/researchers)--FIX--, [Steven M. Hyman[/researchers/[steven-hyman[/researchers/[steven-hyman[/researchers/[steven-hyman--TEMP--/researchers)--FIX--, [R. Terry Bartus[/researchers/[tomas-bartus[/researchers/[tomas-bartus[/researchers/[tomas-bartus--TEMP--/researchers)--FIX--
- [Researchers and Institutions Index[/[researchers[/[researchers[/[researchers[/[researchers[/[researchers[/researchers
- [Diseases Index[/[diseases[/[diseases[/[diseases[/[diseases[/[diseases[/diseases
- [Mechanisms Index[/[mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/[mechanisms[/mechanisms
The study of John Hardy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- A mutation in APP protects against Alzheimer's disease. Nature, 2011. DOI
- The amyloid hypothesis of Alzheimer's disease. Science, 2015. DOI
- ORCID profile: 0000-0002-5389-5055
Page auto-generated from NeuroWiki researcher database. Last updated: 2026-02-26.
John A. Hardy is a Professor of Neuroscience and Chair of the Department of Neuroscience at University College London (UCL). He is one of the most influential Alzheimer's disease researchers in the world, known for his groundbreaking work on the genetic basis of neurodegenerative diseases. His research has transformed our understanding of Alzheimer's disease pathogenesis.
- Genetic Causes of Alzheimer's: Discovered that mutations in the APP gene cause early-onset familial Alzheimer's disease, establishing the amyloid hypothesis.
- Presenilin Genes: Identified [presenilin-1[/entities/[psen1[/entities/[psen1[/entities/[psen1--TEMP--/entities)--FIX-- (PSEN1) and [presenilin-2[/entities/[psen2[/entities/[psen2[/entities/[psen2--TEMP--/entities)--FIX-- (PSEN2) mutations as causes of familial Alzheimer's disease.
- Amyloid Hypothesis: Formulated the amyloid cascade hypothesis, which posits that [amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta[/entities/[amyloid-beta--TEMP--/entities)--FIX-- accumulation is the primary trigger of Alzheimer's disease pathology.
- Parkinson's Disease Genetics: Contributed to the identification of LRRK2 mutations causing familial Parkinson's disease.
In 1989, Dr. Hardy and his colleague Gerald Higgins discovered the first mutation in the APP gene in a family with early-onset Alzheimer's disease. This landmark discovery provided the first direct evidence that Alzheimer's disease could be caused by a genetic mutation and led to the formulation of the amyloid cascade hypothesis, which has dominated Alzheimer's research for decades.
His work established that overproduction of amyloid-beta due to genetic mutations causes early-onset Alzheimer's, while impaired clearance may contribute to late-onset disease.
¶ Awards and Recognition
- Breakthrough Prize in Life Sciences (2020) for work on Alzheimer's disease
- The Brain Prize (2018) for contributions to dementia research
- Royal Society Fellow
- Knight Bachelor (KBE) for services to science
- Over 600 publications with more than 60,000 citations
- [Alzheimer's Disease[/diseases/alzheimer'[s-disease[/diseases/alzheimer'[s-disease[/diseases/alzheimer'[s-disease--TEMP--/diseases)--FIX--
- [Amyloid-Beta[/proteins/[amyloid-beta[/proteins/[amyloid-beta[/proteins/[amyloid-beta--TEMP--/proteins)--FIX--
- [Presenilin[/proteins/[presenilin[/proteins/[presenilin[/proteins/[presenilin--TEMP--/proteins)--FIX--
- [APP Gene[/genes/[app[/genes/[app[/genes/[app--TEMP--/genes)--FIX--
- [University College London[/institutions/[university-college-london[/institutions/[university-college-london[/institutions/[university-college-london--TEMP--/institutions)--FIX--
John A. Hardy is a Professor of Neuroscience and Chair of the Department of Neuroscience at University College London (UCL). He is one of the most influential Alzheimer's disease researchers in the world, known for his groundbreaking work on the genetic basis of neurodegenerative diseases. His research has transformed our understanding of Alzheimer's disease pathogenesis.
- Genetic Causes of Alzheimer's: Discovered that mutations in the APP gene cause early-onset familial Alzheimer's disease, establishing the amyloid hypothesis.
- Presenilin Genes: Identified presenilin-1 (PSEN1) and presenilin-2 (PSEN2) mutations as causes of familial Alzheimer's disease.
- Amyloid Hypothesis: Formulated the amyloid cascade hypothesis, which posits that amyloid-beta accumulation is the primary trigger of Alzheimer's disease pathology.
- Parkinson's Disease Genetics: Contributed to the identification of LRRK2 mutations causing familial Parkinson's disease.
In 1989, Dr. Hardy and his colleague Gerald Higgins discovered the first mutation in the APP gene in a family with early-onset Alzheimer's disease. This landmark discovery provided the first direct evidence that Alzheimer's disease could be caused by a genetic mutation and led to the formulation of the amyloid cascade hypothesis, which has dominated Alzheimer's research for decades.
His work established that overproduction of amyloid-beta due to genetic mutations causes early-onset Alzheimer's, while impaired clearance may contribute to late-onset disease.
¶ Awards and Recognition
- Breakthrough Prize in Life Sciences (2020) for work on Alzheimer's disease
- The Brain Prize (2018) for contributions to dementia research
- Royal Society Fellow
- Knight Bachelor (KBE) for services to science
- Over 600 publications with more than 60,000 citations
- [Alzheimer's Disease[/diseases/alzheimer'[s-disease[/diseases/alzheimer'[s-disease[/diseases/alzheimer'[s-disease--TEMP--/diseases)--FIX--
- [Amyloid-Beta[/proteins/[amyloid-beta[/proteins/[amyloid-beta[/proteins/[amyloid-beta--TEMP--/proteins)--FIX--
- [Presenilin[/proteins/[presenilin[/proteins/[presenilin[/proteins/[presenilin--TEMP--/proteins)--FIX--
- [APP Gene[/genes/[app[/genes/[app[/genes/[app--TEMP--/genes)--FIX--
- [University College London[/institutions/[university-college-london[/institutions/[university-college-london[/institutions/[university-college-london--TEMP--/institutions)--FIX--
John A. Hardy is a Professor of Neuroscience and Chair of the Department of Neuroscience at University College London (UCL). He is one of the most influential Alzheimer's disease researchers in the world, known for his groundbreaking work on the genetic basis of neurodegenerative diseases. His research has transformed our understanding of Alzheimer's disease pathogenesis.
- Genetic Causes of Alzheimer's: Discovered that mutations in the APP gene cause early-onset familial Alzheimer's disease, establishing the amyloid hypothesis.
- Presenilin Genes: Identified presenilin-1 (PSEN1) and presenilin-2 (PSEN2) mutations as causes of familial Alzheimer's disease.
- Amyloid Hypothesis: Formulated the amyloid cascade hypothesis, which posits that amyloid-beta accumulation is the primary trigger of Alzheimer's disease pathology.
- Parkinson's Disease Genetics: Contributed to the identification of LRRK2 mutations causing familial Parkinson's disease.
In 1989, Dr. Hardy and his colleague Gerald Higgins discovered the first mutation in the APP gene in a family with early-onset Alzheimer's disease. This landmark discovery provided the first direct evidence that Alzheimer's disease could be caused by a genetic mutation and led to the formulation of the amyloid cascade hypothesis, which has dominated Alzheimer's research for decades.
His work established that overproduction of amyloid-beta due to genetic mutations causes early-onset Alzheimer's, while impaired clearance may contribute to late-onset disease.
¶ Awards and Recognition
- Breakthrough Prize in Life Sciences (2020) for work on Alzheimer's disease
- The Brain Prize (2018) for contributions to dementia research
- Royal Society Fellow
- Knight Bachelor (KBE) for services to science
- Over 600 publications with more than 60,000 citations
- [Alzheimer's Disease[/diseases/alzheimer'[s-disease[/diseases/alzheimer'[s-disease[/diseases/alzheimer'[s-disease--TEMP--/diseases)--FIX--
- [Amyloid-Beta[/proteins/[amyloid-beta[/proteins/[amyloid-beta[/proteins/[amyloid-beta--TEMP--/proteins)--FIX--
- [Presenilin[/proteins/[presenilin[/proteins/[presenilin[/proteins/[presenilin--TEMP--/proteins)--FIX--
- [APP Gene[/genes/[app[/genes/[app[/genes/[app--TEMP--/genes)--FIX--
- [University College London[/institutions/[university-college-london[/institutions/[university-college-london[/institutions/[university-college-london--TEMP--/institutions)--FIX--
Dr. Hardy has published over 500 papers on the genetics of neurodegenerative diseases, including:
- Discovery of APP and PSEN mutations in familial Alzheimer's
- Genetic risk factors for Parkinson's disease
- [Tau[/entities/[tau-protein[/entities/[tau-protein[/entities/[tau-protein--TEMP--/entities)--FIX-- gene mutations in frontotemporal dementia
- Genetic architecture of neurodegenerative diseases
- Translational genetics for therapeutic development
His work established the amyloid hypothesis of Alzheimer's disease.
Dr. Hardy's research has transformed the field by:
- Identifying causative genes for familial Alzheimer's
- Establishing genetic risk factors for sporadic disease
- Guiding therapeutic target selection
- Enabling genetic testing for at-risk individuals
¶ Awards and Recognition
Dr. Hardy is a fellow of the Royal Society and has received the Breakthrough Prize in Life Sciences for his work on Alzheimer's disease genetics.
- [Alzheimer's Disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--
- [Genetics[/mechanisms/[genetics[/mechanisms/[genetics[/mechanisms/[genetics--TEMP--/mechanisms)--FIX--
- [Amyloid Precursor Protein[/proteins/[app[/proteins/[app[/proteins/[app--TEMP--/proteins)--FIX--
- [Presenilin[/proteins/[presenilin[/proteins/[presenilin[/proteins/[presenilin--TEMP--/proteins)--FIX--
- Hardy J, et al. "Amyloid and Alzheimer's disease." Nature Reviews Neuroscience. 2024.
- Hardy J, Selkoe DJ. "The amyloid hypothesis of Alzheimer's disease." Science. 2023.
- Ryman DC, et al. "Genetic forms of Alzheimer's disease." Brain. 2022.
- Hardy J. "The genetics of Alzheimer's disease." Acta Neuropathologica. 2021.